about
Cancer preceding giant cell arteritis: a case-control studySolid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term followup of a multicenter longitudinal cohort.Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritisCurrent state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.The spectrum of paraneoplastic cutaneous vasculitis in a defined population: incidence and clinical features.Malignancy risk in vasculitisPulmonary manifestations of anti-neutrophil cytoplasmic antibody (ANCA)-positive vasculitis.Morbidity of solid cancer in Behςet's disease: analysis of 11 cases in a series of 506 patientsThe kidney in oncology.Myelodysplasia and malignancy-associated vasculitis.TNF-α blocker therapy and solid malignancy risk in ANCA-associated vasculitis.Adenocarcinoma of the seminal vesicles complicated by antineutrophil cytoplasmic antibody vasculitis: a case report and review of the literature.Key advances in the clinical approach to ANCA-associated vasculitis.Onco-nephrology: current concepts and future perspectives.A case of MPO- and PR3-ANCA-negative pauci-immune renal-limited small-vessel vasculitis associated with endometrial neuroendocrine small cell carcinoma.Development of features of glomerulopathy in tumor-bearing rats: a potential model for paraneoplastic glomerulopathy.Lymphoma presenting as Henoch-Schönlein purpura.Diagnostic and therapeutic management of Churg-Strauss syndrome.Novel strategy for the treatment of refractory vasculitis syndrome.Microscopic polyangitis complicating double carcinoma of the stomach and duodenum: improvement after the resection of these carcinomas.Extranodal NK/T-cell Lymphoma, Nasal Type Accompanied by PR3-ANCA-associated Glomerulonephritis.Long-term safety and efficacy of rituximab in 7 Japanese patients with ANCA-associated vasculitis.Polyangiitis with granulomatosis as a paraneoplastic syndrome of B-cell lymphoma of the lacrimal gland.Beneficial Effect of Rituximab in the Treatment of Esophageal Cancer-Associated Pauci-Immune Glomerulonephritis.[S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis].Clinical features and outcome of microscopic polyangiitis under a new consensus algorithm of ANCA-associated vasculitides in Korea.Rectal Adenocarcinoma As An Uncommon Cause of Immunoglobulin A Vasculitis (Henoch-Schönlein Purpura)
P2860
Q34012677-4883327C-0E52-4298-99C1-840833B87237Q34628409-AA6695B7-E00A-44F8-A496-F24A6EDCBF7BQ34684475-9CF722EC-186B-4734-80AE-0C1D9E69E29CQ35579503-E59AA6CC-81B0-4FA2-8BD6-49ED5EA04AEFQ36009027-69E416B2-8A37-4E61-929E-C07532369BFAQ36059573-74385E29-FE97-4461-8036-A07FFD39A59FQ36370934-02993F89-C6BD-4267-87FE-0C08ED426F93Q36872907-12B0564B-F472-4873-AB75-32E441B57F7AQ36900332-2D9F71CD-80E1-4D7A-872D-7A74F73E31D1Q38028379-45B8B19C-3353-46E5-A73B-D21A3B1812D2Q38041477-CDBF6A1E-FC41-439F-87BF-DCBB6CA3BA8BQ38085731-0B8C15FA-11CE-4BC8-ADE2-BE0F808F711FQ38224803-CA3E10EE-5884-44A0-B967-5CEF552963E3Q38382457-FACF8706-8228-48AA-A75B-93FF8F62F99CQ38783710-74B3F22A-2294-4AEA-A4CE-CF6D84379D43Q39453326-A106EBF6-CAF4-4E27-B448-043066D0416BQ39721534-4A41F38F-957E-444A-BA4D-03461614C8C0Q39872550-4E719412-8681-4B43-86BC-D40D254B3385Q40066118-B61CCB06-F922-4A43-96D0-40D372CF21F0Q40376050-CE9B7032-DA52-4614-AA0C-98B8AA310A01Q41564144-6A59FD0F-F6CA-44AC-804A-94479966DB10Q41605329-BB9B9ACB-6833-48F9-8818-ADA5CBF89000Q42728473-D35B76B2-83BF-4D78-B195-FA5E2D2112E5Q46402507-C4CA70F9-2D4F-44EB-8AE4-8136B3C6C5ADQ50076914-3690C269-ACC9-4AFD-9EA9-EF38F3D68600Q51534074-5A17D399-FC38-41B7-B05B-B921CC984F48Q58134132-0D9A447B-59CE-44E5-924C-5EB29EFEB90C
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Malignancy is increased in ANCA-associated vasculitis.
@ast
Malignancy is increased in ANCA-associated vasculitis.
@en
type
label
Malignancy is increased in ANCA-associated vasculitis.
@ast
Malignancy is increased in ANCA-associated vasculitis.
@en
prefLabel
Malignancy is increased in ANCA-associated vasculitis.
@ast
Malignancy is increased in ANCA-associated vasculitis.
@en
P2093
P356
P1433
P1476
Malignancy is increased in ANCA-associated vasculitis.
@en
P2093
P304
P356
10.1093/RHEUMATOLOGY/KEH374
P577
2004-08-17T00:00:00Z